BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1465 related articles for article (PubMed ID: 19172627)

  • 1. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In reference to Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy (Laryngoscope 119:359-369, 2009).
    Nakashima T; Teranishi M; Yoshida T
    Laryngoscope; 2009 Dec; 119(12):2480; author reply 2481-2. PubMed ID: 19688859
    [No Abstract]   [Full Text] [Related]  

  • 3. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
    Battaglia A; Burchette R; Cueva R
    Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.
    Kakehata S; Sasaki A; Oji K; Futai K; Ota S; Makinae K; Shinkawa H
    Otol Neurotol; 2006 Aug; 27(5):604-8. PubMed ID: 16788418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.
    Ho HG; Lin HC; Shu MT; Yang CC; Tsai HT
    Laryngoscope; 2004 Jul; 114(7):1184-9. PubMed ID: 15235345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G; Herráiz C
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
    Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
    Van Wijck F; Staecker H; Lefebvre PP
    Acta Otolaryngol; 2007 Oct; 127(10):1012-7. PubMed ID: 17851934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.
    Klemm E; Bepperling F; Burschka MA; Mösges R;
    Otol Neurotol; 2007 Feb; 28(2):157-70. PubMed ID: 17255882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
    Arslan N; Oğuz H; Demirci M; Şafak MA; İslam A; Kaytez SK; Samim E
    Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden sensorineural hearing loss: results of intratympanic steroids as salvage treatment.
    Dispenza F; De Stefano A; Costantino C; Marchese D; Riggio F
    Am J Otolaryngol; 2013; 34(4):296-300. PubMed ID: 23357592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss].
    Yang J; Huang L; Shi J; Li Y; Wu H; Kong W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jul; 24(13):594-7. PubMed ID: 20842947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss.
    Battista RA
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):902-5. PubMed ID: 15944562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL.
    Hong SM; Park CH; Lee JH
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):579-83. PubMed ID: 19861194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic and systemic steroids for sudden hearing loss.
    Koltsidopoulos P; Bibas A; Sismanis A; Tzonou A; Seggas I
    Otol Neurotol; 2013 Jun; 34(4):771-6. PubMed ID: 23652330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects.
    Plontke SK; Zimmermann R; Zenner HP; Löwenheim H
    Otol Neurotol; 2006 Oct; 27(7):912-7. PubMed ID: 17006340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.